Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3556 AL 3570

Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases

Dos Reis Rosa Franco G, Smid S, Viegas C.

Curr Neuropharmacol. 2021;19(4):449-464. doi: 10.2174/1570159X18666200720172624.

Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals

Singh M, Singh SP, Yadav D, Agarwal M, Agarwal S, Agarwal V, Swargiary G, Srivastava S, Tyagi S, Kaur R, Mani S.

Curr Gene Ther. 2021;21(1):23-42. doi: 10.2174/1566523220999200817164907.

Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration

Shafi S, Singh A, Gupta P, Chawla PA, Fayaz F, Sharma A, Pottoo FH.

CNS Neurol Disord Drug Targets. 2021;20(1):54-67. doi: 10.2174/1871527319666200903162200.

Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation

Sun HJ, Wu ZY, Nie XW, Bian JS.

Curr Neuropharmacol. 2021;19(6):868-884. doi: 10.2174/1570159X18666200905143550.

Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases

Benn CL, Gibson KR, Reynolds DS.

J Huntingtons Dis. 2021;10(1):203-220. doi: 10.3233/JHD-200421.

Nanotechnology: Its Application in Treating Neurodegenerative Diseases

Naz F, Siddique YH.

CNS Neurol Disord Drug Targets. 2021;20(1):34-53. doi: 10.2174/1871527319666200916121515.

Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV

Nash B, Irollo E, Brandimarti R, Meucci O.

Methods Mol Biol. 2021;2201:139-162. doi: 10.1007/978-1-0716-0884-5_13.

Saccharomyces cerevisiae in neuroscience: how unicellular organism helps to better understand prion protein?

Ishikawa T.

Neural Regen Res. 2021 Mar;16(3):489-495. doi: 10.4103/1673-5374.293137.

Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations

Vishwas S, Gulati M, Kapoor B, Gupta S, Singh SK, Awasthi A, Khan A, Goyal A, Bansal A, Baishnab S, Singh TG, Arora S, Porwal O, Kumar A, Kumar V.

Curr Neuropharmacol. 2021;19(7):957-989. doi: 10.2174/1570159X18666201109090824.

Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications

Siafaka PI, Özcan Bülbül E, Dilsiz P, Karantas ID, Okur ME, Üstündağ Okur N.

J Drug Target. 2021 Jun;29(5):476-490. doi: 10.1080/1061186X.2020.1859516. Epub 2021 Jan 5.

Sirtuin3 in Neurological Disorders

Sherin F, Gomathy S, Antony S.

Curr Drug Res Rev. 2021;13(2):140-147. doi: 10.2174/2589977512666201207200626.

Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer

Palmer CS, Anderson AJ, Stojanovski D.

FEBS Lett. 2021 Apr;595(8):1107-1131. doi: 10.1002/1873-3468.14022. Epub 2021 Jan 28.

Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R.

Adv Exp Med Biol. 2021;1264:81-92. doi: 10.1007/978-3-030-57369-0_6.

Artificial miRNAs as therapeutic tools: Challenges and opportunities

Kotowska-Zimmer A, Pewinska M, Olejniczak M.

Wiley Interdiscip Rev RNA. 2021 Jul;12(4):e1640. doi: 10.1002/wrna.1640. Epub 2021 Jan 1.

Neuroprotection through G-CSF: recent advances and future viewpoints

Rahi V, Jamwal S, Kumar P.

Pharmacol Rep. 2021 Apr;73(2):372-385. doi: 10.1007/s43440-020-00201-3. Epub 2021 Jan 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias